NYXH vs AVAV vs KTOS vs INSP vs NVCR

For growth investors, Nyxoah S.

A. (NYXH) is the stronger pick with 121. 6% revenue growth year-over-year, versus 8. 3% for NovoCure Limited (NVCR). Inspire Medical Systems, Inc. (INSP) offers the better valuation at 8. 7x trailing P/E (47. 6x forward), making it the more compelling value choice. Analysts rate Nyxoah S. A. (NYXH) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Inspire Medical Systems, Inc.

(INSP) is the cheapest at 8. 7x versus Kratos Defense & Security Solutions, Inc. at 444. 2x. On forward P/E, Inspire Medical Systems, Inc. is actually cheaper at 47. 6x.

Over the past 5 years, Kratos Defense & Security Solutions, Inc.

(KTOS) delivered a total return of +119. 5%, compared to -94. 9% for Nyxoah S. A. (NYXH). Over 10 years, the gap is even starker: KTOS returned +1355% versus NYXH's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Inspire Medical Systems, Inc.

(INSP) is the lower-risk stock at 1. 16β versus NovoCure Limited's 2. 21β — meaning NVCR is approximately 91% more volatile than INSP relative to the S&P 500. On balance sheet safety, Inspire Medical Systems, Inc. (INSP) carries a lower debt/equity ratio of 4% versus 86% for Nyxoah S. A. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nyxoah S.

A. (NYXH) is pulling ahead at 121. 6% versus 8. 3% for NovoCure Limited (NVCR). On earnings-per-share growth, the picture is similar: Inspire Medical Systems, Inc. grew EPS 179. 4% year-over-year, compared to -30. 9% for Nyxoah S. A.. Over a 3-year CAGR, NYXH leads at 48. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Inspire Medical Systems, Inc.

(INSP) is the more profitable company, earning 15. 9% net margin versus -899. 1% for Nyxoah S. A. — meaning it keeps 15. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INSP leads at 5. 6% versus -827. 8% for NYXH. At the gross margin level — before operating expenses — INSP leads at 85. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Inspire Medical Systems, Inc.

(INSP) trades at 47. 6x forward P/E versus 75. 9x for Kratos Defense & Security Solutions, Inc. — 28. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NYXH: 331. 7% to $6. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Kratos Defense & Security Solutions, Inc.

(KTOS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1355% 10Y return). Nyxoah S. A. (NYXH) carries a higher beta of 2. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KTOS: +1355%, NYXH: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NYXH (Healthcare) and AVAV (Industrials) and KTOS (Industrials) and INSP (Healthcare) and NVCR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NYXH is a small-cap high-growth stock; AVAV is a small-cap quality compounder stock; KTOS is a mid-cap high-growth stock; INSP is a small-cap deep-value stock; NVCR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.